Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1354 studies found for:    MACULAR DEGENERATION
Show Display Options
Rank Status Study
1 Completed Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Condition: Advanced Age-related Macular Degeneration
Intervention: Biological: LFG316
2 Active, not recruiting Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention:
3 Withdrawn Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: Telescope prosthesis;   Device: WA-NG Telescope Prothesis
4 Recruiting OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: OZURDEX
5 Not yet recruiting Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention: Device: Ocusweep system
6 Recruiting Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Conditions: Macular Degeneration;   Stargardt's Macular Dystrophy
Intervention: Procedure: Subretinal transplantation
7 Unknown  Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
8 Active, not recruiting Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)
Condition: Age-related Macular Degeneration
Interventions: Drug: Omega-3 fatty acids (fish oil);   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin D3 placebo;   Dietary Supplement: Fish oil placebo
9 Completed
Has Results
Sirolimus for Advanced Age-Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Geographic Atrophy
Intervention: Drug: Sirolimus
10 Active, not recruiting S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Conditions: Cataract;   Macular Degeneration
Interventions: Drug: selenium;   Drug: vitamin E;   Drug: vitamin E placebo;   Drug: selenium placebo
11 Completed Evaluation of Optical Coherence Tomography.
Conditions: Age-Related Macular Degeneration;   Choroidal Vessels; Anastomosis
Intervention: Other: tests
12 Completed Antioxidant Systems and Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention:
13 Completed VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Other: No treatment
14 Completed Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Conditions: Age Related Macular Degeneration;   Macular Degeneration;   AMD
Intervention: Drug: HuCNS-SC cells
15 Terminated
Has Results
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration;   Age-related Macular Degeneration
Interventions: Drug: Everolimus;   Drug: Ranibizumab
16 Completed Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
Conditions: Neovascular Age-elated Macular Degeneration (Wet AMD);   Exudative Macular Degeneration
Interventions: Drug: LFG316;   Drug: Placebo
17 Completed
Has Results
A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.
Condition: Exudative Age-related Macular Degeneration
Intervention: Drug: Macugen
18 Completed Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
19 Completed Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
Conditions: Age-related Macular Degeneration;   Pigment Epithelial Detachment;   Neovascular Macular Degeneration;   Wet Macular Degeneration
Intervention: Drug: ranibizumab
20 Completed
Has Results
Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice
Condition: Age-related Macular Degeneration
Intervention: Other: no intervention

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years